Cite
Vallo S, Michaelis M, Gust KM, et al. Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts. BMC Res Notes. 2016;9(1):454doi: 10.1186/s13104-016-2256-3.
Vallo, S., Michaelis, M., Gust, K. M., Black, P. C., Rothweiler, F., Kvasnicka, H. M., Blaheta, R. A., Brandt, M. P., Wezel, F., Haferkamp, A., & Cinatl, J. (2016). Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts. BMC research notes, 9(1), 454. https://doi.org/10.1186/s13104-016-2256-3
Vallo, Stefan, et al. "Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts." BMC research notes vol. 9,1 (2016): 454. doi: https://doi.org/10.1186/s13104-016-2256-3
Vallo S, Michaelis M, Gust KM, Black PC, Rothweiler F, Kvasnicka HM, Blaheta RA, Brandt MP, Wezel F, Haferkamp A, Cinatl J. Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts. BMC Res Notes. 2016 Sep 27;9(1):454. doi: 10.1186/s13104-016-2256-3. PMID: 27677700; PMCID: PMC5039786.
Copy
Download .nbib